CTSH Cognizant Technology Solutions (CTSH) Insider Trading, Ownership & Congress Trades
Software & IT · Services-computer programming services · CIK 0001058290
Congress · 1Form 144 · 5
Funds added, last quarter
476
13F, latest reported quarter
Conversions, 180 days
81
Codes C/M, not in net · no price filed
What the filings say about CTSH
Insiders, 180 days
-$813.8K net sold
1 buyer · 3 sellers · 40% of sales under a 10b5-1 plan
Congress, 1 year
1 bought · 2 sold
Latest: sale, 2026-04-14
Planned sales (Form 144), 90 days
$966.1K
5 notices
Cognizant Technology Solutions insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, COGNIZANT TECHNOLOGY SOLUTIONS CORP insiders sold a net $813.8K of stock across 69 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 15 earlier Form 4 trades (code P or S) here by this insider (15 sales), the last on Sep 14, 2026.
- The trade is 12.4% of the 1,124 shares held after it.
- 1 other insider sold within 30 days.
- 476 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Controller & CAO Kerdman Alina sold about $7.9K of CTSH under a 10b5-1 plan on Sep 30, 2026; 1 other insider sold within 30 days and 476 funds added in the latest 13F quarter.Context
- 14 earlier Form 4 trades (code P or S) here by this insider (14 sales), the last on Aug 31, 2026.
- The trade is 11.9% of the 1,129 shares held after it.
- 1 other insider sold within 30 days.
- 476 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Controller & CAO Kerdman Alina sold about $8.4K of CTSH under a 10b5-1 plan on Sep 14, 2026; 1 other insider sold within 30 days and 476 funds added in the latest 13F quarter.Context
- 7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Aug 3, 2026.
- The trade is 6.3% of the 39,909 shares held after it.
- 2 other insiders sold within 30 days.
- 476 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CLO, CAO & Corporate Secretary Kim John Sunshin sold about $158.4K of CTSH under a 10b5-1 plan on Sep 2, 2026; 2 other insiders sold within 30 days and 476 funds added in the latest 13F quarter.Context
- 13 earlier Form 4 trades (code P or S) here by this insider (13 sales), the last on Jul 1, 2026.
- The trade is 17.0% of the 848 shares held after it.
- 2 other insiders sold within 30 days.
- 476 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Controller & CAO Kerdman Alina sold about $9.1K of CTSH under a 10b5-1 plan on Aug 31, 2026; 2 other insiders sold within 30 days and 476 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Dec 9, 2024.
- The trade is 26.0% of the 46,111 shares held after it.
- 2 other insiders sold within 30 days.
- 476 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Dalal Jatin P sold about $669.2K of CTSH on Aug 3, 2026, the largest insider sale at the company since 2024; 2 other insiders sold within 30 days and 476 funds added in the latest 13F quarter.69 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$813.8K over 180 days
-$995.6K over 90 days
more than 59% of Software & IT
Congress
1 member bought in the last year
the lowest in Software & IT
Funds
476 funds bought in last quarter
more than 92% of Software & IT
Revenue
+7.0% year over year
below 56% of Software & IT
Margin
10.6% net margin
more than 74% of Software & IT
Buybacks
$444.0M repurchased, FY to 2026-03-31
more than 80% of Software & IT
Short interest
7.4% of the float short (float per yahoo 2026-10-26) · 4.7 days to cover · settled 2026-09-30
more than 75% of Software & IT
What changed in the last 30 days
Oct 2SVP, Controller & CAO Kerdman Alina sold $7.9K under a 10b5-1 plan (Sep 30)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Sep 30Officer ALINA KERDMAN filed to sell $7.9K by Sep 30 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Watch CTSH
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+4.9%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CTSH: institutional holders (13F)
13F holdings, latest reported quarter
46,183,240 sh
$1.8B
30,950,850 sh
$1.2B
26,529,172 sh
$1.0B
26,148,721 sh
$1.0B
25,304,648 sh
$980.0M
Congress trades in CTSH
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2026-04-14 · disclosed 24 days later
$1,001 - $15,000
Sold 2026-03-17 · disclosed 17 days later
$15,001 - $50,000
Bought 2026-03-13 · disclosed 25 days later
$1,001 - $15,000
Sold 2025-07-16 · disclosed 28 days later
$1,001 - $15,000
Bought 2025-07-10 · disclosed 34 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CTSH planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
ALINA KERDMAN
Filed 2026-09-30
$7.9K
ALINA KERDMAN
Filed 2026-09-14
$8.0K
ALINA KERDMAN
Filed 2026-08-31
$9.2K
JATIN DALAL
Filed 2026-08-03
$664.2K
JOHN S KIM
Filed 2026-08-03
$276.8K
CTSH mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Monarch Dividend Plus Index ETF
$2.3M position · as of 2026-05-31
3.8%
Kotak India Equity Fund
$7.9M position · as of 2026-07-31
3.4%
Classic Value Fund
$17.4M position · as of 2026-07-31
3.2%
Pzena U.S. Large Cap Value ETF
$1.9M position · as of 2026-05-31
3.1%
Invesco Comstock Select Fund
$25.6M position · as of 2026-07-31
3.0%
Pzena Emerging Markets Value Fund
$112.8M position · as of 2026-05-31
2.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Cognizant Technology Solutions Corporation Political Action Committee (Cognizant Pac)
Cycle 2026 · $106K spent
$70.7K
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Mr.Kumar
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$16.8M
$14.3M
$5.8M
-0%
+66%
2022
$17.9M
-$949.6K
$4.3M
-28%
+5%
2021
$19.7M
$22.4M
$5.7M
+10%
+29%
2020
$13.8M
$21.9M
$7.5M
+34%
+44%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $813.8K sold by insiders over 180 days, 476 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $966.1K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
CTSH financials
Revenue growth
+7.0%
XBRL, annual
Net margin
10.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$21.4B
four quarters, 2025-04-01 to 2026-03-31
Revenue, TTM CTSH
| FY Dec 2025 | $21.1B |
| FY Dec 2024 | $19.7B |
| FY Dec 2023 | $19.4B |
| FY Dec 2022 | $19.4B |
| FY Dec 2021 | $18.5B |
| Mar 2026 | $5.4B |
| Dec 2025 | $5.3B |
| Sep 2025 | $5.4B |
| Jun 2025 | $5.2B |
| Mar 2025 | $5.1B |
| Dec 2024 | $5.1B |
| Sep 2024 | $5.0B |
| Jun 2024 | $4.8B |
At each fiscal year end
Single quarter
Net margin, TTM
+10.4%
net income over revenue, 2025-04-01 to 2026-03-31
Net margin, TTM CTSH
| FY Dec 2025 | +10.6% |
| FY Dec 2024 | +11.3% |
| FY Dec 2023 | +11.0% |
| FY Dec 2022 | +11.8% |
| FY Dec 2021 | +11.5% |
| Mar 2026 | +12.2% |
| Dec 2025 | +12.2% |
| Sep 2025 | +5.1% |
| Jun 2025 | +12.3% |
| Mar 2025 | +13.0% |
| Dec 2024 | +10.7% |
| Sep 2024 | +11.5% |
| Jun 2024 | +11.7% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$2.5B
operating cash flow minus capex, 2025-04-01 to 2026-03-31
Free cash flow, TTM CTSH
| FY Dec 2025 | $2.6B |
| FY Dec 2024 | $1.8B |
| FY Dec 2023 | $2.0B |
| FY Dec 2022 | $2.2B |
| FY Dec 2021 | $2.2B |
| Mar 2026 | $198.0M |
| Dec 2025 | $781.0M |
| Sep 2025 | $1.2B |
| Jun 2025 | $331.0M |
| Mar 2025 | $323.0M |
| Dec 2024 | $837.0M |
| Sep 2024 | $791.0M |
| Jun 2024 | $183.0M |
At each fiscal year end
Single quarter
Debt to equity
0.04x
long-term 2026-03-31 plus current 2026-03-31; equity 2026-03-31
Debt to equity CTSH
| FY Dec 2025 | 0.04x |
| FY Dec 2024 | 0.06x |
| FY Dec 2023 | 0.05x |
| FY Dec 2022 | 0.05x |
| FY Dec 2021 | 0.06x |
| Mar 2026 | 0.04x |
| Dec 2025 | 0.04x |
| Sep 2025 | 0.04x |
| Jun 2025 | 0.04x |
| Mar 2025 | 0.04x |
| Dec 2024 | 0.06x |
| Sep 2024 | 0.08x |
| Jun 2024 | 0.04x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
4.85x
TTM operating cash flow over long-term 2026-03-31 plus current 2026-03-31
Cash flow to debt CTSH
| FY Dec 2025 | 5.01x |
| FY Dec 2024 | 2.34x |
| FY Dec 2023 | 3.65x |
| FY Dec 2022 | 3.98x |
| FY Dec 2021 | 3.76x |
| Mar 2026 | 4.85x |
| Dec 2025 | 5.01x |
| Sep 2025 | 5.04x |
| Jun 2025 | 4.33x |
| Mar 2025 | 4.05x |
| Dec 2024 | 2.34x |
| Sep 2024 | 1.60x |
| Jun 2024 | 3.09x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+14.9%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on equity CTSH
| FY Dec 2025 | +15.2% |
| FY Dec 2024 | +16.2% |
| FY Dec 2023 | +16.7% |
| FY Dec 2022 | +18.8% |
| FY Dec 2021 | +18.7% |
| Mar 2026 | +14.9% |
| Dec 2025 | +15.2% |
| Sep 2025 | +14.5% |
| Jun 2025 | +16.7% |
| Mar 2025 | +16.6% |
| Dec 2024 | +16.2% |
| Sep 2024 | +16.5% |
| Jun 2024 | +16.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+11.0%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on assets CTSH
| FY Dec 2025 | +11.0% |
| FY Dec 2024 | +11.7% |
| FY Dec 2023 | +11.7% |
| FY Dec 2022 | +12.8% |
| FY Dec 2021 | +12.3% |
| Mar 2026 | +11.0% |
| Dec 2025 | +11.0% |
| Sep 2025 | +10.6% |
| Jun 2025 | +12.6% |
| Mar 2025 | +12.3% |
| Dec 2024 | +11.7% |
| Sep 2024 | +11.8% |
| Jun 2024 | +12.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+15.6%
operating income after a 36.1% effective tax rate, over long-term 2026-03-31 plus current 2026-03-31 plus average of 2025-03-31 and 2026-03-31 minus cash
Return on invested capital CTSH
| FY Dec 2025 | +16.4% |
| FY Dec 2024 | +17.8% |
| FY Dec 2023 | +18.6% |
| FY Dec 2022 | +20.8% |
| FY Dec 2021 | +21.7% |
| Mar 2026 | +15.6% |
| Dec 2025 | +16.4% |
| Sep 2025 | +15.9% |
| Jun 2025 | +18.1% |
| Mar 2025 | +18.2% |
| Dec 2024 | +17.8% |
| Sep 2024 | +17.0% |
| Jun 2024 | +17.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+20.1%
operating income (EBIT proxy) over average of 2025-03-31 and 2026-03-31 minus current liabilities
Return on capital employed CTSH
| FY Dec 2025 | +20.3% |
| FY Dec 2024 | +18.3% |
| FY Dec 2023 | +18.1% |
| FY Dec 2022 | +20.6% |
| FY Dec 2021 | +20.4% |
| Mar 2026 | +20.1% |
| Dec 2025 | +20.3% |
| Sep 2025 | +19.6% |
| Jun 2025 | +19.4% |
| Mar 2025 | +19.1% |
| Dec 2024 | +18.3% |
| Sep 2024 | +18.1% |
| Jun 2024 | +18.4% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
15.33x
close 2026-10-23 over four quarters of diluted EPS, 2025-04-01 to 2026-03-31
P/E, trailing CTSH
| FY Dec 2025 | 18.24x |
| FY Dec 2024 | 17.05x |
| FY Dec 2023 | 17.94x |
| FY Dec 2022 | 12.97x |
| FY Dec 2021 | 21.96x |
| Mar 2026 | 13.34x |
| Dec 2025 | 18.24x |
| Sep 2025 | 15.56x |
| Jun 2025 | 15.86x |
| Mar 2025 | 16.11x |
| Dec 2024 | 17.05x |
| Sep 2024 | 17.04x |
| Jun 2024 | 15.45x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$32.5B
market value at close 2026-10-23 on 2026-04-24 shares, plus long-term 2026-03-31 plus current 2026-03-31, minus cash 2026-03-31
Enterprise value CTSH
| FY Dec 2025 | $38.7B |
| FY Dec 2024 | $36.8B |
| FY Dec 2023 | $35.9B |
| FY Dec 2022 | $27.8B |
| FY Dec 2021 | $45.5B |
| Mar 2026 | $28.4B |
| Dec 2025 | $38.7B |
| Sep 2025 | $31.0B |
| Jun 2025 | $37.3B |
| Mar 2025 | $36.5B |
| Dec 2024 | $36.8B |
| Sep 2024 | $37.5B |
| Jun 2024 | $32.2B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+7.4%
TTM free cash flow over market value at close 2026-10-23
FCF yield CTSH
| FY Dec 2025 | +6.5% |
| FY Dec 2024 | +4.8% |
| FY Dec 2023 | +5.3% |
| FY Dec 2022 | +7.6% |
| FY Dec 2021 | +4.8% |
| Mar 2026 | +8.4% |
| Dec 2025 | +6.5% |
| Sep 2025 | +8.1% |
| Jun 2025 | +5.9% |
| Mar 2025 | +5.6% |
| Dec 2024 | +4.8% |
| Sep 2024 | +4.3% |
| Jun 2024 | +4.8% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -3%, PEG needs growth
PEG, trailing CTSH
| FY Dec 2025 | 20.57x |
| FY Dec 2024 | 2.39x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 1.42x |
| FY Dec 2021 | 0.38x |
| Mar 2026 | n/a |
| Dec 2025 | 20.57x |
| Sep 2025 | n/a |
| Jun 2025 | 1.34x |
| Mar 2025 | 1.16x |
| Dec 2024 | 2.39x |
| Sep 2024 | 1.62x |
| Jun 2024 | 5.51x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $21.1B | $19.7B | $19.4B | $19.4B |
| Operating income | $3.4B | $2.9B | $2.7B | $3.0B |
| Net income | $2.2B | $2.2B | $2.1B | $2.3B |
| EPS (diluted) | 4.56 | 4.51 | 4.21 | 4.41 |
| Operating cash flow | $2.9B | $2.1B | $2.3B | $2.6B |
| Cash | $1.9B | $2.2B | $2.6B | $2.2B |
| Long-term debt | $543.0M | $875.0M | $606.0M | $638.0M |
| Buybacks | $1.4B | $605.0M | $1.1B | $1.4B |
| Dividends paid | $610.0M | $600.0M | $591.0M | $564.0M |
SEC XBRL, fiscal years, as known on 2026-10-27
CTSH Stock Sonar score 6/7 axes
Find similar shapesCompareCTSH ranks highest on financial health (81st percentile) and profitability (74th), and lowest on risk and compliance (35th), among Software & IT peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CTSH filings, in plain words
Are Cognizant Technology Solutions insiders buying or selling CTSH?
In the 180 days to 2026-10-27, Cognizant Technology Solutions insiders were net sellers, a net $813.8K: $209.8K of purchases and $1.0M of sales reported on Form 4, by 1 buyer and 3 sellers.
Have members of Congress traded CTSH?
Yes. In the year to 2026-10-27, 1 House member disclosed buying CTSH and 2 House members disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-04-14.
Are there planned insider sales of CTSH?
Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $966.1K of stock; the latest, by ALINA KERDMAN, was filed 2026-09-30.
Read the full summary
In the 180 days to 2026-10-27, Cognizant Technology Solutions insiders were net sellers of CTSH, a net $813.8K across purchases and sales reported on Form 4 by 1 buyer and 3 sellers. 40% of the 10 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-27, 1 member of Congress disclosed buying CTSH and 2 members disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-04-14. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $966.1K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
